Zacks Research Issues Positive Outlook for ResMed Earnings
ResMed Inc. (NYSE:RMD – Free Report) – Equities researchers at Zacks Research raised their Q3 2025 earnings per share estimates for ResMed in a report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will post earnings of $2.33 per share for the quarter, up from their […]
ResMed Inc. (NYSE:RMD – Free Report) – Equities researchers at Zacks Research raised their Q3 2025 earnings per share estimates for ResMed in a report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will post earnings of $2.33 per share for the quarter, up from their […]
